Hydromorphone Hydrochloride Injection, Solution
Product Images NDC 63323-854

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 63323-854). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Hyd0u 0000 01)

FDA Label Image

85107 Vial (Hyd0u 0000 02)

85107 Vial (Hyd0u 0000 02)
Hydromorphone Hydrochloride Injection, USP, 10 mg/mL (50 mg per 5 mL) vial by Fresenius Kabi USA, LLC. The label indicates a high potency formula for preparation of large-volume parenteral solutions, single dose 5 mL vial, preservative free, with storage instructions at 20° to 25°C (68° to 77°F).*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Hydromorphone Hydrochloride Injection, USP, 10 mg per mL. This is a preservative-free, high potency formula supplied in a 1 mL single dose vial. The product is labeled for prescription use and distributed by Fresenius Kabi USA, LLC. The label includes the lot and expiration sections and a barcode with its NDC.*
FDA Label Image

Figure (Hyd0u 0000 04)

Figure (Hyd0u 0000 04)
Hydromorphone Hydrochloride Injection, USP label for 10 mg/mL strength, 50 mL single dose vial. The label states '500 mg per 50 mL' and identifies it as a high potency formula intended for preparation of large-volume parenteral solutions. It includes preservative-free formulation details and storage instructions, labeled by Fresenius Kabi USA, LLC.*
FDA Label Image

Hyrdromorphone-85203 (Hyd0u 0000 05)

Hyrdromorphone-85203 (Hyd0u 0000 05)
Label for Hydromorphone Hydrochloride Injection, USP, 1 mg per mL in a 1 mL single dose vial by Fresenius Kabi USA, LLC. The label states it is preservative free, for intramuscular, intravenous, or subcutaneous use, and includes a lot/expiration area and barcode.*
FDA Label Image

Hydromorphone-85303 (Hyd0u 0000 06)

Hydromorphone-85303 (Hyd0u 0000 06)
Hydromorphone Hydrochloride Injection, USP 2 mg per mL single dose vial label. The label indicates it is preservative free and intended for intramuscular, intravenous, or subcutaneous use. The product is from Fresenius Kabi USA, LLC and includes regulatory and barcode information.*
FDA Label Image

Hydromorphone-85403 (Hyd0u 0000 07)

Hydromorphone-85403 (Hyd0u 0000 07)
Hydromorphone Hydrochloride Injection, USP 4 mg per mL single-dose vial label. The injectable solution is preservative-free and indicated for intramuscular, intravenous, or subcutaneous use. The label includes the manufacturer name Fresenius Kabi and a barcode with lot/expiration space.*
FDA Label Image

Carton (Hyd0u 0000 08)

Carton (Hyd0u 0000 08)
Packaging label for Hydromorphone Hydrochloride Injection, USP, 50 mg per 5 mL (10 mg per mL) by Fresenius Kabi USA, LLC. The label indicates high potency formula intended for preparation of large-volume parenteral solutions. It includes dosage strength, preservative-free status, storage instructions, and package quantity as 10 single-dose vials of 5 mL each.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Hydromorphone Hydrochloride Injection, USP, 10 mg per mL, a high potency formula for preparation of large-volume parenteral solutions. The label shows this product is preservative free, intended for single dose vials of 10 x 1 mL, and for Rx use only. The labeler is Fresenius Kabi USA, LLC, Lake Zurich, IL. It includes storage instructions and notations about the container closure.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Package Label (PRINCIPAL DISPLAY)
Label for Hydromorphone Hydrochloride Injection, USP, 10 mg/mL (500 mg per 50 mL) solution for injection by Fresenius Kabi USA, LLC. The label states this is a high potency formula for large-volume parenteral solutions. It is preservative free with storage instructions at 20° to 25°C (68° to 77°F). The package contains 1 single dose vial of 50 mL.*
FDA Label Image

Carton (Hyd0u 0000 11)

Carton (Hyd0u 0000 11)
Label for Hydromorphone Hydrochloride Injection, USP 1 mg per mL by Fresenius Kabi USA, LLC. The label includes dosage strength details, route of administration (intramuscular, intravenous, subcutaneous), package size of 2 x 1 mL single-dose vials, storage instructions, and barcodes. The design features blue and white color blocks with the product name prominently displayed.*
FDA Label Image

Carton (Hyd0u 0000 12)

Carton (Hyd0u 0000 12)
Label for Hydromorphone Hydrochloride Injection, USP 2 mg/mL solution. The label shows the product name prominently with dosage strength 2 mg per mL and indicates it is an injection. The labeler is Fresenius Kabi USA, LLC. It includes barcodes, dosing route information for intramuscular, intravenous, and subcutaneous use, and storage instructions.*
FDA Label Image

Carton (Hyd0u 0000 13)

Carton (Hyd0u 0000 13)
Packaging label for Hydromorphone Hydrochloride Injection, USP, 4 mg per mL solution. The label indicates this is a prescription injectable solution manufactured by Fresenius Kabi USA, LLC. The label includes the drug name, strength, dosage form, route of administration (intramuscular, intravenous, subcutaneous), and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.